LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microarrays Uncover Connection Between Genomic Errors and Neurologic Disorders

By Labmedica staff writers
Posted on 04 Feb 2008
Microarrays are providing the design capabilities, sensitivity, and resolution, which enable scientists to discover a mechanism of genomic errors associated with certain diseases.

Genomic copy number changes or translocations occurring during cell division are associated with a wide range of diseases especially developmental and neurologic disorders such as Alzheimer's, Parkinson's, and Potocki-Lupski Syndrome. When the DNA addition or deletion occurs in the wrong place, another genomic-based disorder such as Pelizaeus-Merzbacher disease (PMD) can occur. PMD is a progressive degenerative disorder of the central nervous system in which motor abilities and intellectual function deteriorate. This X-chromosome-linked neurodevelopment disorder affects males and can have particularly devastating consequences.

Scientists at Baylor College of Medicine (BCM; Houston, TX, USA), used their own SurePrint in situ synthesis platform together with Agilent (Santa Clara, CA, USA) microarrays to observe the unique way that DNA additions or deletions introduced in genes during cell division were associated the diseases. The mechanism for human genomic disorders in which segments of DNA are added or deleted during replication is called replication Fork Stalling and Template Switching (FoSTes).

Jennifer Lee, Ph.D., a member of the Baylor team, was studying PMD and found genomic changes that previous theory about DNA recombination did not explain. In some places, extra genetic material was found in the middle of a different duplication.

"The Agilent microarrays were essential in enabling us to elucidate this novel mechanism,” said BCM's James R. Lupski, M.D., Ph.D., professor of molecular and human genetics, and senior investigator in this project. Prof. Lupski pioneered the emerging field of copy number variation (CNV) in the early 1990s in the quest to understand genetic variation and the multiple molecular mechanisms for disease. Now, he and his colleagues have discovered that the DNA replication process can stall, and sometimes, switch to a different "template” rather than restarting in the same place. In addition to disease research, according to Dr. Lupski, the FoSTeS mechanism could also play an important role in studies investigating human evolution.

The findings were published in the January 2007 issue of the journal Cell.


Related Links:
Baylor College of Medicine
Agilent

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Latest Molecular Diagnostics News

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
04 Feb 2008  |   Molecular Diagnostics

Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
04 Feb 2008  |   Molecular Diagnostics

Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
04 Feb 2008  |   Molecular Diagnostics